Real world data of Type 2 Diabetes Mellitus (T2DM) obese patients using another GLP1 receptor agonist (GLP1–RA) and switching to Semaglutide in Spain
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2020 ◽
Vol 34
(7)
◽
pp. 107587
Keyword(s):
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):
2016 ◽
Vol 10
(5)
◽
pp. 1122-1129
◽
Keyword(s):
2020 ◽
Keyword(s):